Cronos Group Quarterly Cash Flow Statement
NASDAQ: CRONHealth Care Medicinal Chemicals and Botanical Products USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cronos Group free cash flow
In the quarter ended Jun 30, 2026, Cronos Group generated $24.0 million of operating cash flow and spent $1.7 million on capital expenditures. That left free cash flow of $22.3 million, a free-cash-flow margin of 42.0% of revenue. Cronos Group returned $16.1 million to shareholders through share repurchases, equal to 72% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Cronos Group cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 35.66M | 15.71M | -491.00K | 28.32M | -38.48M | 7.72M | 43.94M | 7.32M | -8.76M | -2.48M | -45.03M | -1.77M |
| Net Income growth (YoY) | — | +103.43% | -101.12% | +286.69% | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.37M | 3.73M | 3.66M | 3.53M | 4.20M | 2.84M | 2.52M | 3.57M | 1.51M | 1.73M | 1.18M | 2.15M |
| Stock-Based Compensation | 1.56M | 1.31M | 1.25M | 2.33M | 1.38M | 2.09M | 2.19M | 2.26M | 2.24M | 2.02M | 1.93M | 1.95M |
| Change in Working Capital | 1.32M | -4.20M | 5.45M | -6.65M | -8.58M | -15.62M | 8.30M | 3.31M | 1.02M | -11.25M | 19.09M | 7.76M |
| Operating Cash Flow | 24.01M | 10.90M | 11.84M | 13.31M | 2.82M | -2.10M | 7.72M | 11.58M | 1.74M | -2.20M | 16.82M | -183.00K |
| Capital Expenditures | -1.74M | -1.88M | -2.14M | -4.48M | -3.84M | -15.26M | -3.54M | -6.42M | -729.00K | -1.72M | -1.22M | 11.00K |
| Investing Cash Flow | -358.30M | 38.03M | 2.78M | -23.00M | -983.00K | -55.36M | -5.03M | -818.00K | -8.56M | 189.56M | 81.89M | 157.57M |
| Share Repurchases | -16.13M | -16.73M | -4.27M | -1.86M | -3.61M | 0 | 0 | 0 | — | — | — | — |
| Financing Cash Flow | -20.88M | -18.27M | -7.42M | -1.87M | -7.69M | -2.93M | -313.00K | -13.00K | -260.00K | -645.00K | -218.00K | -30.00K |
| Net Change in Cash | -354.84M | 30.06M | 7.62M | -10.25M | -3.40M | -60.99M | -3.23M | 13.85M | -6.92M | 185.82M | 97.64M | 162.23M |
| Free Cash Flow | 22.27M | 9.02M | 9.70M | 8.83M | -1.02M | -17.35M | 4.18M | 5.17M | 1.01M | -3.93M | 15.60M | -172.00K |
This table shows 12 quarterly periods of Cronos Group's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CRON's reporting calendar. What is a cash flow statement?